Durvalumab vs Levothyroxine

## Durvalumab vs Levothyroxine: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Levothyroxine**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Levothyroxine**: Synthetic thyroid hormone T4 replacement.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Levothyroxine — 6-7 days.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Levothyroxine — C15H11I4NO4.

**Molecular Weight**: Durvalumab — N/A; Levothyroxine — 776.8700 g/mol.

**Type**: Durvalumab — Antibody; Levothyroxine — Small molecule.